Comparison of effects of different heparins on thrombin activatable fibrinolysis inhibitor in hemodialyzed patients.

about

Vascular adhesion protein-1 in hemodialysis and hemodiafiltration patients: effect of single hemodialysis session on its level in regard to type of anticoagulant Where and When To Inject Low Molecular Weight Heparin in Hemodiafiltration? A Cross Over Randomised Trial

P2860

Q33599915-7BD2CF10-5568-400D-9159-462F56E0642B Q35663917-AD7B22F8-97DC-49B4-AADB-569BE0143177

P2860

Comparison of effects of different heparins on thrombin activatable fibrinolysis inhibitor in hemodialyzed patients.

Item

http://www.wikidata.org/entity/Q45208151

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Comparison of effects of diffe ...... itor in hemodialyzed patients.

@en

Comparison of effects of diffe ...... itor in hemodialyzed patients.

@nl

type

Item

label

Comparison of effects of diffe ...... itor in hemodialyzed patients.

@en

Comparison of effects of diffe ...... itor in hemodialyzed patients.

@nl

prefLabel

Comparison of effects of diffe ...... itor in hemodialyzed patients.

@en

Comparison of effects of diffe ...... itor in hemodialyzed patients.

@nl

P1476

Comparison of effects of diffe ...... bitor in hemodialyzed patients

@en

P2093

Jacek S Małyszko

http://www.w3.org/2001/XMLSchema#string

Jolanta Małyszko

http://www.w3.org/2001/XMLSchema#string

Michał Myśliwiec

http://www.w3.org/2001/XMLSchema#string

Tomasz Hryszko

http://www.w3.org/2001/XMLSchema#string

P2860

Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway.

Association of a single nucleotide polymorphism in CPB2 encoding the thrombin-activable fibrinolysis inhibitor (TAF1) with blood pressure.

Acute phase mediators modulate thrombin-activable fibrinolysis inhibitor (TAFI) gene expression in HepG2 cells.

Anticoagulation intensity sufficient for haemodialysis does not prevent activation of coagulation and platelets.

A possible role of thrombin-activatable fibrinolysis inhibitor in disturbances of fibrinolytic system in renal transplant recipients.

Patients on peritoneal dialysis but not on hemodialysis have elevated concentration and activity of thrombin-activatable fibrinolysis inhibitor.

Influence of low molecular weight heparin compared to conventional heparin for anticoagulation during haemodialysis on low density lipoprotein subclasses.

Different effects of enoxaparin and unfractionated heparin on extrinsic blood coagulation during haemodialysis: a prospective study.

Thrombin-activatable fibrinolysis inhibitor in kidney transplant recipient with dyslipidemia.

Comparison of low-molecular-weight heparin (enoxaparin sodium) and standard unfractionated heparin for haemodialysis anticoagulation.

P304

624-629

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000082862

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Krystyna Pawlak

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15627717

http://www.w3.org/2001/XMLSchema#string

Comparison of effects of different heparins on thrombin activatable fibrinolysis inhibitor in hemodialyzed patients.

about

P2860

P2860

Comparison of effects of different heparins on thrombin activatable fibrinolysis inhibitor in hemodialyzed patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698